Atypical GPI-anchored T-cadherin stimulates angiogenesis in vitro and in vivo

被引:52
|
作者
Philippova, Maria
Banfi, Andrea
Ivanov, Danila
Gianni-Barrera, Roberto
Allenspach, Roy
Erne, Paul
Resink, Therese
机构
[1] Univ Basel Hosp, Cardiovasc Signalling Grp, CH-4031 Basel, Switzerland
[2] Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland
[3] Univ Basel Hosp, Cell & Gene Therapy Grp, CH-4031 Basel, Switzerland
[4] Univ Basel Hosp, Dept Surg, CH-4031 Basel, Switzerland
关键词
angiogenesis; cadherin; endothelial cell differentiation; VEGF;
D O I
10.1161/01.ATV.0000238356.20565.92
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-T-cadherin (T-cad) is an atypical GPI-anchored member of the cadherin superfamily. In vascular tissue, T-cad expression is increased during atherosclerosis, restenosis, and tumor neovascularization. In vitro, overexpression and/or homophilic ligation of T-cad on endothelial cells (ECs) facilitates migration, proliferation, and survival. This study investigated T-cad effects on angiogenesis. Methods and Results-In vitro, T-cad homophilic ligation induced arrangement of ECs into a capillary-like network in a 2-dimensional model of EC differentiation and stimulated in-gel endothelial sprout outgrowth in an EC spheroid model and a modified Nicosia tissue assay. Sprouting from spheroids composed of adenoviral-infected T-cad overexpressing ECs or T-cad siRNA transfected ECs were significantly increased or reduced, respectively. In vivo, T-cad potentiated VEGF effects on neovascularization in a model of myoblast-mediated gene transfer to mouse skeletal muscle; vessel caliber after co-delivery of T-cad and VEGF was significantly greater than after delivery of VEGF alone. Conclusions-We unequivocally identify T-cad as a novel modulator of angiogenesis and suggest that this molecule can be exploited as a target for modulation of therapeutic angiogenesis, as well as for prevention of pathological conditions associated with abnormal neovascularization.
引用
收藏
页码:2222 / 2230
页数:9
相关论文
共 50 条
  • [1] Atypical GPI-anchored T-cadherin stimulates angiogenesis in vitro.
    Philippova, M
    Ivanov, D
    Allenspach, R
    Erne, P
    Resink, T
    JOURNAL OF VASCULAR RESEARCH, 2005, 42 : 47 - 48
  • [2] Atypical GPI-anchored T-cadherin modulates VEGF-induced angiogenesis in vivo
    Philippova, M.
    Banfi, A.
    Gianni'barrera, R.
    Ivanov, D.
    Erne, P.
    Resink, T. J.
    EUROPEAN HEART JOURNAL, 2007, 28 : 611 - 611
  • [3] Potential membrane adaptors for atypical GPI-anchored T-cadherin
    Ivanov, D.
    Philippova, M.
    Joshi, M.
    Erne, P.
    Resink, T.
    EUROPEAN HEART JOURNAL, 2007, 28 : 109 - 109
  • [4] Identification of membrane adaptor molecules for atypical GPI-anchored T-cadherin
    Ivanov, D.
    Philippova, M.
    Erne, P.
    Resink, T.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 191 - 191
  • [5] The Missing Protein: Is T-Cadherin a Previously Unknown GPI-Anchored Receptor on Platelets?
    Balatskaya, Maria N.
    Baglay, Alexandra, I
    Balatskiy, Alexander, V
    MEMBRANES, 2021, 11 (03)
  • [6] COEXPRESSION WITH N-CADHERIN REDISTRIBUTES GPI-ANCHORED T-CADHERIN INTO CELL-CELL CONTACT SITES
    VESTAL, DJ
    RANSCHT, B
    FASEB JOURNAL, 1993, 7 (07): : A1271 - A1271
  • [7] Different spatiotemporal organization of GPI-anchored T-cadherin in response to low-density lipoprotein and adiponectin
    Balatskaya, Maria N.
    Sharonov, Georgy V.
    Baglay, Alexandra I.
    Rubtsov, Yury P.
    Tkachuk, Vsevolod A.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2019, 1863 (11):
  • [8] GPI-anchored T-cadherin released from cells: new implications for signaling mechanisms and clinical practice?
    Philippova, M.
    Kyriakakis, E.
    Joshi, M. B.
    Rupp, K.
    Erne, P.
    Resink, T. J.
    EUROPEAN HEART JOURNAL, 2008, 29 : 243 - 244
  • [9] T-cadherin is a GPI-anchored receptor for hexameric and high-molecular weight forms of Acrp30/adiponectin
    Hug, C
    Wang, J
    Lodish, HF
    MOLECULAR BIOLOGY OF THE CELL, 2004, 15 : 180A - 180A
  • [10] GPI-ANCHORED T-CADHERIN IS SHED FROM ENDOTHELIAL CELLS AND IS TRANSFERRED TO LIPOPROTEINS: NEW IMPLICATIONS FOR SIGNALING MECHANISMS AND CLINICAL PRACTICE?
    Philippova, M.
    Ivanov, D.
    Joshi, M. B.
    Rupp, K.
    Erne, P.
    Resink, T.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 65 - 66